GCT President Takes Part in CTAD Congress

Dr. Jeffrey Apter is taking part in the CTAD Alzheimer’s congress. The event is being held November 9-12 at the Boston Park Plaza. It brings together key industry professionals and Key Opinion Leaders (KOLs) in Alzheimer’s disease to discuss the latest innovations and effective treatment development.

Currently, there are a few options available to mitigate the symptoms of the disease, but no cure has been invented yet. The research is ongoing and is especially active. Dr. Jeffrey Apter is a practicing psychiatrist and a Key Opinion Leader in Alzheimer’s disease with years of research experience and multiple publications on the topic. GCT has managed numerous Alzheimer’s trials both in the US and globally.

Please reach out to us at bd@gctrials.com to request more information.